Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide
Stefanie Krug, Manish Gupta, Pankaj Kumar, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Combating sepsis-induced acute lung injury: PARP1 inhibition mediates oxidative stress mitigation and miR-135a-5p/SMAD5/Nanog axis drives regeneration
Salman Khan, Almaz Zaki, Muhammad Irfan Masood, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114166-114166
Closed Access
Effects of adenosine triphosphate, thiamine pyrophosphate, melatonin, and liv-52 on subacute pyrazinamide proliferation hepatotoxicity in rats
Sedat Çiftel, Serpil Çiftel, Durdu Altuner, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access
Multi-Omics Integration Reveals Mitochondrial Gene Regulation as a Determinant of Tuberculosis Susceptibility: A Mendelian Randomization Approach
Tingting Fang, Yu Chen, Feifei Yuan, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 749-749
Open Access
Expanding the Perspective on PARP1 and Its Inhibitors in Cancer Therapy: From DNA Damage Repair to Immunomodulation
Flurina Böhi, Michael O. Hottiger
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1617-1617
Open Access | Times Cited: 2
Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis
Rubhana Raqib, Protim Sarker
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1497-1497
Open Access | Times Cited: 1
Cardiovascular Involvement in Tuberculosis Patients Treated in Southern Africa
Daryoush Samim, Guy Muula, Nicolas Banholzer, et al.
JACC Advances (2024) Vol. 4, Iss. 1, pp. 101427-101427
Open Access | Times Cited: 1
Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies
Hina Amer, Nirmala Chandralega Kampan, Catherine Itsiopoulos, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4187-4187
Open Access | Times Cited: 1
siRNA Targeting PARP-1 Alleviates Diabetic Peripheral Neuropathy in a Streptozotocin-Induced Rat Model
Moqbel Ali Moqbel Redhwan, Hariprasad M.G, Suman Samaddar, et al.
Journal of drug targeting (2024) Vol. 33, Iss. 3, pp. 424-435
Closed Access
Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells
N. A. Kolotyeva, Alexander A. Groshkov, Nataliya A. Rozanova, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1556-1556
Open Access
Clinical Significance of Preoperative Pyrazinamide-Containing Therapy in Tuberculous Constrictive Pericarditis
Likui Fang, Wenfeng Yu, Guocan Yu, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 131-139
Open Access
Colon-Targeted Poly(ADP-Ribose) Polymerase Inhibitors Synergize Therapeutic Effects of Mesalazine Against Rat Colitis Induced by 2,4-Dinitrobenzenesulfonic Acid
Changyu Kang, Jaejeong Kim, Yeon-Hee Jeong, et al.
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1546-1546
Open Access
Page 1

Scroll to top